Lamivudine in the treatment of acute hepatitis B [3]

New England Journal of Medicine

Volumn 343, Issue 15, 2000, Pages 1123-1124

  Reshef, Ron ^a   Sbeit, Wisam ^a   Tur Kaspa, Ran ^b  

^a WESTERN GALILEE HOSPITAL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; LAMIVUDINE; VIRUS DNA;

ACUTE HEPATITIS; AGED; CASE REPORT; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LIVER FIBROSIS; LIVER FUNCTION TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ACUTE DISEASE; AGED; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HUMANS; LAMIVUDINE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0034642049     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200010123431513     Document Type: Letter

References (0)